Ibritumomab Tiuxetan and Tacrolimus Extended-Release Tablets
Determining the interaction of Ibritumomab Tiuxetan and Tacrolimus Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: tacrolimus
Brand name: Astagraf XL, Envarsus XR, Prograf, Hecoria
Synonyms: Tacrolimus (oral and injection), Tacrolimus (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Tacrolimus Granules for Suspension
- Ibritumomab Tiuxetan-Tacrolimus Injection
- Ibritumomab Tiuxetan-Tacrolimus Intravenous
- Ibritumomab Tiuxetan-Tacrolimus oral and injection
- Ibritumomab Tiuxetan-Tacrolimus Oral, Intravenous
- Ibritumomab Tiuxetan-Tactinal
- Tacrolimus Extended-Release Tablets-Ibrutinib
- Tacrolimus Extended-Release Tablets-Ibrutinib Capsules
- Tacrolimus Extended-Release Tablets-Ibrutinib Tablets
- Tacrolimus Extended-Release Tablets-Ibu
- Tacrolimus Extended-Release Tablets-IBU Tablets
- Tacrolimus Extended-Release Tablets-Ibu-2